[go: up one dir, main page]

MXPA02006965A - Solvato de etanol de (-) -cis-2 -(2-clorofenil) -5, 7-dihidroxi -8[4r-(3s -hidroxi -1-metil] piperidinil] -4h-1 -benzopiran-4 -ona. - Google Patents

Solvato de etanol de (-) -cis-2 -(2-clorofenil) -5, 7-dihidroxi -8[4r-(3s -hidroxi -1-metil] piperidinil] -4h-1 -benzopiran-4 -ona.

Info

Publication number
MXPA02006965A
MXPA02006965A MXPA02006965A MXPA02006965A MXPA02006965A MX PA02006965 A MXPA02006965 A MX PA02006965A MX PA02006965 A MXPA02006965 A MX PA02006965A MX PA02006965 A MXPA02006965 A MX PA02006965A MX PA02006965 A MXPA02006965 A MX PA02006965A
Authority
MX
Mexico
Prior art keywords
cis2
piperidinyl
4hminu
ethanol solvate
ethanol
Prior art date
Application number
MXPA02006965A
Other languages
English (en)
Inventor
Kurt M Kesseler
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of MXPA02006965A publication Critical patent/MXPA02006965A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La presente invencion se refiere a una forma de solvato de etanol de (-) -cis-2- (2-clorofenil) -5, 7-dihidroxi- 8[4R-(3S-hidroxi-l-metil) piperidinil]-4H-1-benzopiran-4-ona (Forma II), un metodo de elaboracion de la Forma II y una composicion que comprende la Forma II.
MXPA02006965A 2000-01-18 2001-01-08 Solvato de etanol de (-) -cis-2 -(2-clorofenil) -5, 7-dihidroxi -8[4r-(3s -hidroxi -1-metil] piperidinil] -4h-1 -benzopiran-4 -ona. MXPA02006965A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48781500A 2000-01-18 2000-01-18
PCT/US2001/000520 WO2001053294A1 (en) 2000-01-18 2001-01-08 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one

Publications (1)

Publication Number Publication Date
MXPA02006965A true MXPA02006965A (es) 2004-09-06

Family

ID=23937213

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02006965A MXPA02006965A (es) 2000-01-18 2001-01-08 Solvato de etanol de (-) -cis-2 -(2-clorofenil) -5, 7-dihidroxi -8[4r-(3s -hidroxi -1-metil] piperidinil] -4h-1 -benzopiran-4 -ona.

Country Status (26)

Country Link
EP (1) EP1252155B1 (es)
JP (1) JP2003520798A (es)
KR (1) KR100825530B1 (es)
CN (1) CN1395577A (es)
AR (1) AR027226A1 (es)
AT (1) ATE284400T1 (es)
AU (1) AU2001230869A1 (es)
BR (1) BR0107724A (es)
CA (1) CA2397594C (es)
CZ (1) CZ301235B6 (es)
DE (1) DE60107652T2 (es)
DK (1) DK1252155T3 (es)
EA (1) EA005182B1 (es)
ES (1) ES2228800T3 (es)
HU (1) HU225155B1 (es)
IL (2) IL150643A0 (es)
MX (1) MXPA02006965A (es)
NO (1) NO322626B1 (es)
NZ (1) NZ520281A (es)
PL (1) PL201690B1 (es)
PT (1) PT1252155E (es)
SI (1) SI1252155T1 (es)
SK (1) SK287216B6 (es)
TW (1) TWI293072B (es)
WO (1) WO2001053294A1 (es)
ZA (1) ZA200205640B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190175598A1 (en) 2016-08-23 2019-06-13 Eisai R&D Management Co., Ltd. Combination therapies for the treatment of hepatocellular carcinoma
US11083722B2 (en) 2017-03-16 2021-08-10 Eisai R&D Management Co., Ltd. Combination therapies for the treatment of breast cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (es) * 1986-04-11 1989-02-04 Hoechst India
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5908934A (en) * 1996-09-26 1999-06-01 Bristol-Myers Squibb Company Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs

Also Published As

Publication number Publication date
DE60107652D1 (de) 2005-01-13
PT1252155E (pt) 2005-04-29
WO2001053294A1 (en) 2001-07-26
TWI293072B (en) 2008-02-01
NZ520281A (en) 2004-04-30
EP1252155A1 (en) 2002-10-30
CZ301235B6 (cs) 2009-12-16
CN1395577A (zh) 2003-02-05
HU225155B1 (en) 2006-07-28
DK1252155T3 (da) 2005-04-04
NO322626B1 (no) 2006-11-06
NO20023385L (no) 2002-08-27
KR100825530B1 (ko) 2008-04-25
SK287216B6 (sk) 2010-03-08
NO20023385D0 (no) 2002-07-12
SK10372002A3 (sk) 2002-12-03
IL150643A (en) 2009-08-03
AU2001230869A1 (en) 2001-07-31
HUP0204297A3 (en) 2005-04-28
HUP0204297A2 (hu) 2003-04-28
EA200200776A1 (ru) 2002-12-26
PL355992A1 (en) 2004-05-31
KR20020069514A (ko) 2002-09-04
BR0107724A (pt) 2002-10-01
JP2003520798A (ja) 2003-07-08
EP1252155B1 (en) 2004-12-08
CA2397594C (en) 2010-03-23
ZA200205640B (en) 2003-11-26
EA005182B1 (ru) 2004-12-30
DE60107652T2 (de) 2005-12-22
IL150643A0 (en) 2003-02-12
PL201690B1 (pl) 2009-04-30
CA2397594A1 (en) 2001-07-26
AR027226A1 (es) 2003-03-19
CZ20022467A3 (cs) 2002-10-16
ES2228800T3 (es) 2005-04-16
ATE284400T1 (de) 2004-12-15
SI1252155T1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
AU2000242834A1 (en) Method and terminal for inputting instructions
AU2001276048A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001279284A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
HUP0001285A3 (en) Pyrrolidine derivatives as protease inhibitors, process for producing them and pharmaceutical compositions containing them
AU2001261566A1 (en) Well service composition and method
AUPR105000A0 (en) Method for generating and detecting marks
AU2002213273A1 (en) Stenoprophiluric matrices, and methods of making and using the same
EP1164965A4 (en) ENDODONTIC INSTRUMENT, INSTRUMENT SHAPE AND MANUFACTURING METHOD
AU2002228692A1 (en) 3-(2,4-dimethylthiazol-5-yl) indeno(1,2-c)pyrazol-4-one derivatives as cdk inhibitors
AU2002225894A1 (en) Methods and compositions for the control of coccidiosis
AU2002211652A1 (en) Method of making an electrode
PL358334A1 (en) Digestable chewing gum
PL345528A1 (en) Novel piperidine-4-sulphonamide compounds, method of obtaining them and pharmacological compositions containing such compounds
PL351301A1 (en) Novel inhibitors of metaloprotease, methods of obtaining them and pharmacological composition containing such inhibitors
MXPA02006965A (es) Solvato de etanol de (-) -cis-2 -(2-clorofenil) -5, 7-dihidroxi -8[4r-(3s -hidroxi -1-metil] piperidinil] -4h-1 -benzopiran-4 -ona.
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
AU2001292452A1 (en) Method and generator for inputting characters
AU2002310949A1 (en) Method of producing N-substituted 2,6-dialkyl morpholines
MXPA02007005A (es) Pseudopolimorfo de (-) -cis-2 -(2-clorofenil) -5, 7-dihidorxi -8[4r-(3s-hidroxi -1-meitl) piperidinil] -4h-1-benzopiran -4-ona.
AU7965301A (en) Method for producing polyisobutenes
AU2001271801A1 (en) Compositions and methods for producing recombinant virions
BG104604A (en) Process for the preparation of paroxetin hydrochloride
AU1398500A (en) Process for the production of paroxetine hydrochloride propan-2-ol solvate
AU2002229149A1 (en) Process for producing hydrazinomonosaccharide derivatives and use thereof
PL347056A1 (en) Novel compounds of heterocycloalkylbezocyclobutane and heterocycloarylbenzocyclobutane, method of obtaining them and pharmacological compositions containming such compounds

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights